Current
$193.23B
5-Year Average
$149.87B
All-Time High
$210.77B
All-Time Low
$33.73B
Market cap daily chart for Amgen (AMGN)
Jun 16, 2021 – Jun 12, 2026 · 1,254 trading days
Market Cap growth chart for Amgen (AMGN) from 1985 to 2026
Latest: +8.9%
Market Cap history table for Amgen (AMGN) from 1985 to 2026
| 2026 | $193.23B | +8.9% | +$15.83B | ||
| 2025 | $177.40B | +25.8% | +$36.40B | ||
| 2024 | $141.01B | -9.0% | −$13.95B | ||
| 2023 | $154.95B | +9.1% | +$12.87B | ||
| 2022 | $142.09B | +10.2% | +$13.18B | ||
| 2021 | $128.91B | -5.0% | −$6.74B | ||
| 2020 | $135.65B | -7.6% | −$11.16B | ||
| 2019 | $146.81B | +13.4% | +$17.36B | ||
| 2018 | $129.46B | +1.3% | +$1.64B | ||
| 2017 | $127.82B | +15.9% | +$17.57B | ||
| 2016 | $110.24B | -11.3% | −$14.10B | ||
| 2015 | $124.34B | +1.4% | +$1.69B | ||
| 2014 | $122.65B | +40.5% | +$35.38B | ||
| 2013 | $87.27B | +28.6% | +$19.43B | ||
| 2012 | $67.84B | +15.8% | +$9.28B | ||
| 2011 | $58.56B | +10.5% | +$5.58B | ||
| 2010 | $52.98B | -8.3% | −$4.78B | ||
| 2009 | $57.76B | -7.0% | −$4.32B | ||
| 2008 | $62.08B | +19.0% | +$9.93B | ||
| 2007 | $52.15B | -35.8% | −$29.14B | ||
| 2006 | $81.29B | -18.1% | −$17.92B | ||
| 2005 | $99.21B | +17.2% | +$14.53B | ||
| 2004 | $84.68B | +1.8% | +$1.51B | ||
| 2003 | $83.17B | +49.2% | +$27.41B | ||
| 2002 | $55.76B | -8.9% | −$5.44B | ||
| 2001 | $61.20B | -11.8% | −$8.15B | ||
| 2000 | $69.36B | +7.1% | +$4.59B | ||
| 1999 | $64.76B | +134.3% | +$37.12B | ||
| 1998 | $27.64B | +86.0% | +$12.78B | ||
| 1997 | $14.86B | -2.7% | −$408.37M | ||
| 1996 | $15.27B | -9.8% | −$1.67B | ||
| 1995 | $16.94B | +103.3% | +$8.60B | ||
| 1994 | $8.33B | +22.9% | +$1.55B | ||
| 1993 | $6.78B | -33.4% | −$3.41B | ||
| 1992 | $10.19B | -1.1% | −$115.42M | ||
| 1991 | $10.30B | +524.7% | +$8.65B | ||
| 1990 | $1.65B | — | — | ||
| 1988 | $576.56M | -5.1% | −$31.07M | ||
| 1987 | $607.63M | +40.1% | +$173.96M | ||
| 1986 | $433.67M | +165.4% | +$270.29M | ||
| 1985 | $163.38M | — | — |
- 2026$193.23B+8.9%
- 2025$177.40B+25.8%
- 2024$141.01B-9.0%
- 2023$154.95B+9.1%
- 2022$142.09B+10.2%
- 2021$128.91B-5.0%
- 2020$135.65B-7.6%
- 2019$146.81B+13.4%
- 2018$129.46B+1.3%
- 2017$127.82B+15.9%
- 2016$110.24B-11.3%
- 2015$124.34B+1.4%
- 2014$122.65B+40.5%
- 2013$87.27B+28.6%
- 2012$67.84B+15.8%
- 2011$58.56B+10.5%
- 2010$52.98B-8.3%
- 2009$57.76B-7.0%
- 2008$62.08B+19.0%
- 2007$52.15B-35.8%
- 2006$81.29B-18.1%
- 2005$99.21B+17.2%
- 2004$84.68B+1.8%
- 2003$83.17B+49.2%
- 2002$55.76B-8.9%
- 2001$61.20B-11.8%
- 2000$69.36B+7.1%
- 1999$64.76B+134.3%
- 1998$27.64B+86.0%
- 1997$14.86B-2.7%
- 1996$15.27B-9.8%
- 1995$16.94B+103.3%
- 1994$8.33B+22.9%
- 1993$6.78B-33.4%
- 1992$10.19B-1.1%
- 1991$10.30B+524.7%
- 1990$1.65B—
- 1988$576.56M-5.1%
- 1987$607.63M+40.1%
- 1986$433.67M+165.4%
- 1985$163.38M—
Market Cap values are taken from Amgen's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's latest reported market cap is $191.41B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2026's annual market cap for Amgen (AMGN) came in at $193.23B – grew 8.9% year-over-year.
Through 2021–2026 (5 years), Amgen market cap delivered a +8.4% annualised rate; sustaining 2 straight years of year-over-year growth.
Across the available history, market cap reached its high of $193.23B in 2026 and its low of $163.38M in 1985.
Amgen Market Cap by Year
Amgen Market Cap 2026: $193.23B
2026's market cap for Amgen came in at $193.23B, grew 8.9% from 2025. This figure represents the highest annual value in the available history.
Amgen Market Cap 2025: $177.40B
Amgen posted market cap of $177.40B in 2025, grew 25.8% from 2024.
Amgen Market Cap 2024: $141.01B
In 2024, Amgen reported market cap of $141.01B, declined 9.0% below 2023.
Amgen Market Cap 2023: $154.95B
Amgen market cap in 2023 was $154.95B, grew 9.1% from 2022.
Amgen Market Cap 2022: $142.09B
Amgen market cap in 2022 was $142.09B.
See more financial history for Amgen (AMGN).
Sector peers by Market Cap
Healthcare peers of Amgen (AMGN), ranked by their latest market cap
| $1.07T | |
| $579.83B | |
| $391.50B | |
| $371.00B | |
| $294.03B | |
| $277.22B | |
| $194.99B | |
| $174.42B |
- $1.07T
- $579.83B
- $391.50B
- $371.00B
- $294.03B
- $277.22B
- $194.99B
- $174.42B
Frequently asked questions
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation